F. HOFFMANN-LA ROCHE AG;INSTITUT PASTEUR;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE;COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
发明人:
Pierre Lafaye,Sylvie Bay,Benoit Delatour,Marc Dhenain,Charles Duyckaerts,Tengfei Li,Matthias Vandesquille,Christian Czech,Fiona Grueninger
申请号：
US15035582
公开号：
US09738712B2
申请日:
2014.11.13
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to variable domain of a camelid heavy-chain antibodies directed to amyloid β and conjugates thereof. The present invention also relates to the use of these antibody conjugates for treating or diagnosing disorders mediated by amyloid β deposits.
